Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor ...
Hosted on MSN22h
CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?CRISPR Therapeutics CRSP stock rose more than 25% in the past week, thanks to the encouraging fourth-quarter 2024 results and ...
AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback